Corey Davis
Stock Analyst at HC Wainwright & Co.
(3.00)
# 1,448
Out of 5,064 analysts
17
Total ratings
75%
Success rate
25.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corey Davis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Reiterates: Neutral | $480 → $390 | $54.28 | +618.50% | 5 | May 12, 2020 | |
| SCYX SCYNEXIS | Assumes: Buy | $50 | $0.68 | +7,252.94% | 3 | May 7, 2018 | |
| VTVT vTv Therapeutics | Downgrades: Neutral | $560 → $40 | $29.86 | +33.96% | 2 | Apr 10, 2018 | |
| LPCN Lipocine | Initiates: Buy | $170 | $3.16 | +5,279.75% | 1 | Mar 29, 2018 | |
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $20 | $4.80 | +316.67% | 2 | Jan 19, 2018 | |
| PCRX Pacira BioSciences | Initiates: Buy | $50 | $23.05 | +116.92% | 3 | Jan 19, 2018 | |
| JAZZ Jazz Pharmaceuticals | Initiates: Neutral | $144 | $176.93 | -18.61% | 1 | Aug 25, 2017 |
Nektar Therapeutics
May 12, 2020
Reiterates: Neutral
Price Target: $480 → $390
Current: $54.28
Upside: +618.50%
SCYNEXIS
May 7, 2018
Assumes: Buy
Price Target: $50
Current: $0.68
Upside: +7,252.94%
vTv Therapeutics
Apr 10, 2018
Downgrades: Neutral
Price Target: $560 → $40
Current: $29.86
Upside: +33.96%
Lipocine
Mar 29, 2018
Initiates: Buy
Price Target: $170
Current: $3.16
Upside: +5,279.75%
Vanda Pharmaceuticals
Jan 19, 2018
Initiates: Buy
Price Target: $20
Current: $4.80
Upside: +316.67%
Pacira BioSciences
Jan 19, 2018
Initiates: Buy
Price Target: $50
Current: $23.05
Upside: +116.92%
Jazz Pharmaceuticals
Aug 25, 2017
Initiates: Neutral
Price Target: $144
Current: $176.93
Upside: -18.61%